Vicore Pharma publishes the Annual Report for 2021

2022-04-07 | Regulatory

Gothenburg, April 7, 2022 –Vicore Pharma Holding AB (publ) (“Vicore”), a clinical-stage pharmaceutical company developing medicines targeting the angiotensin II type 2 receptor (ATRAGs), today announced the publication of the Annual Report for the financial year 2021.

The Annual Report for the financial year 2021 is available on the company’s website: https://vicorepharma.com/investors/financial-reports/

For further information, please contact:
Hans Jeppsson, CFO, tel: +46 70 553 14 65, hans.jeppsson@vicorepharma.com  

This information is information that Vicore Pharma Holding AB (publ) is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 08:00 CET on 7 April 2022.